Demo Sign up Log In

Armata Pharmaceuticals, Inc. Common Stock (ARMP)

SG&A Expenses

$5.24M

Quarterly · Period ending: Jun 30, 2026 · USD

ARMP SG&A Expenses

Latest reported$5.24Mperiod endingJun 30, 2026

Latest reported$5.24Mperiod endingJun 30, 2026

ARMP Quarterly SG&A Expenses ($0.00 → $5.24M)

Quarterly SG&A Expenses

High-resolution chart · PNG

ARMP sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Armata Pharmaceuticals, Inc. Common Stock SG&A Expenses — Quarterly (USD)
Period ending	SG&A Expenses (USD)
Mar 31, 1998	800,000
Dec 31, 1997	700,000
Sep 30, 1997	700,000
Jun 30, 1997	600,000
Mar 31, 1997	800,000
Dec 31, 1996	900,000
Sep 30, 1996	800,000
Jun 30, 1996	600,000
Mar 31, 1996	600,000
Dec 31, 1995	600,000
Sep 30, 1995	400,000
Jun 30, 1995	500,000
Mar 31, 1995	700,000
Dec 31, 1994	500,000
Sep 30, 1994	500,000
Jun 30, 1994	500,000
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.